Category: Press Releases

A Blueprint For Drug/Diagnostic Co-development      Washington, DC, September 30, 2014 – Today, Friends of Cancer Research (Friends) and Alexandria Real Estate Equities, Inc/Alexandria Venture Investments (NYSE:ARE) will host the 3rd Annual Blueprint for Drug/Diagnostic Co-development forum. This annual conference brings together researchers, sponsors, advocates, policy-makers and regulators to develop consensus-driven solutions to address…

Collaboration to feature policy briefings on “Cancer Research in the 21st Century”;  speakers for inaugural event include Dr. Francis Collins, Dr. Ronald DePinho, and moderator Susan Page of USA Today Washington, DC, September 18, 2014 –– The Aspen Institute Health, Medicine, and Society Program and Friends of Cancer Research (Friends) announce a new partnership, which…

Groundbreaking study in squamous cell lung cancer opens at more than a hundred and fifty new locations The Lung-MAP trial, a multi-drug, multi-sub-study, biomarker-driven clinical trial for patients with advanced squamous cell lung cancer, that launched on June 16th 2014, today announced that it has expanded to an additional 169 locations throughout the United States.…

Friends of Cancer Research (Friends) is proud to join our many partner organizations in announcing the launch of the Lung Cancer Master Protocol (Lung-MAP) clinical trial. Lung-MAP is the product of years of collaboration with government, research institutions, patient advocacy groups, and industry, and it is our hope that it will provide a model for…

Chair & Founder Ellen Sigal Participates in Inaugural Roundtable   Executive Director Jeff Allen Testifies Before House Energy and Commerce Committee On May 6, 2014, Friends Chair & Founder, Dr. Ellen Sigal joined NIH Director Francis Collins, FDA’s Dr. Janet Woodcock, as a participant on the same committees’ kickoff event for the “21st Center Cures…

Washington, DC – Friends of Cancer Research (Friends), a Washington, DC-based think tank and advocacy organization, announced the appointment of Joel S. Marcus, Chairman, Chief Executive Officer, and Founder of Alexandria Real Estate Equities, Inc. /Alexandria Venture Investments, to its Board of Directors. In addition to his work in life science real estate, Mr. Marcus…

   2013 Breakthrough Therapies Designation Year-End Update    Designations Granted by the FDA: 37    Requests Denied by the FDA: 70    Designations Announced Publicly by Companies: 28  Cancer: 12  Hepatitis C: 4  Cystic Fibrosis: 2  Autoimmune Disorders: 2 (Lambert Eaton Myasthenic Syndrome)  (Sporadic inclusion body myositis)  Heart Disease: 1  Malaria: 1  Antidote for Factor…

WASHINGTON, DC (December 9, 2013) – Today, Friends of Cancer Research is excited to announce the launch of the online forum “Engaging Innovation.” Leaders from regulation, research, drug development, treatment, and advocacy will share insights and innovations in an ongoing dialogue about the most critical issues in the fight against cancer.  Our inaugural entry is an interview…

APRIL 30, 2013 – WASHINGTON, DC — Friends of Cancer Research (Friends) is proud to honor Ms. Sherry Lansing with the inaugural Ellen V. Sigal Advocacy Leadership Award. Friends is continually cited for changing the landscape of how drugs are researched, evaluated and approved. The truly unique and groundbreaking scientific partnerships, as well as bipartisan…

Washington, D.C. (July 9, 2012) The signing of Food and Drug Administration Safety and Innovation Act (FDASIA) into law today represents the culmination of a year of true collaboration for the best interests of patients. The open, inclusive and constructive dialogue during the formative stages of the fifth Prescription Drug User Fee Act (PDUFA) reauthorization…